TSX · MBX.TO
Microbix Biosystems Inc.
CA$0.29CA$0.00 (0.0%)
Microbix Biosystems Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.12% below the high.
Loading market information…
TSX · BCT.TO · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 07:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
BriaCell Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 74.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow BriaCell Therapeutics Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
BriaCell Therapeutics Corp. is a biotechnology company focused on immuno-oncology, dedicated to developing innovative immune-based therapies for cancer treatment. Its primary therapeutic candidate, Bria-IMT, is a whole-cell cancer vaccine currently undergoing Phase I/IIa clinical trials, where it is being evaluated in combination with the investigational immunotherapy retifanlimab. The company's pipeline also includes Bria-OTS, an accessible, personalized immunotherapy for advanced breast cancer, and BriaDx, a diagnostic test designed to determine patients' HLA types. BriaCell has established a non-exclusive clinical trial collaboration with Incyte Corporation to assess the effects of combining novel therapeutic candidates. Additionally, it holds a cooperative research and development agreement with the National Cancer Institute for preclinical studies to advance and test Bria-OTS cellular immunotherapy as a cancer treatment. The company's headquarters are situated in West Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:22 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| CA$0.00 |
| Q3 2024 | Jun 14, 2024 | CA$0.11+120.0% vs estimate | CA$0.00 |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.29CA$0.00 (0.0%)
Microbix Biosystems Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.12% below the high.
CA$0.08+CA$0.01 (+6.67%)
Resverlogix Corp.’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
CA$0.31+CA$0.02 (+5.08%)
Telescope Innovations Corp.’s quoted price sits in the lower half of its reported 52-week range, 71.82% below the high.
CA$0.14-CA$0.02 (-12.9%)
Perimeter Medical Imaging AI, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
CA$0.11+CA$0.01 (+10.0%)
Rapid Dose Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 42.11% below the high.
CA$0.06CA$0.00 (0.0%)
Hemostemix Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.45% below the high.
CA$0.08CA$0.00 (0.0%)
Greenway Greenhouse Cannabis Corporation’s quoted price sits in the lower half of its reported 52-week range, 63.64% below the high.
CA$0.14-CA$0.01 (-3.45%)
Izotropic Corporation’s quoted price sits in the lower half of its reported 52-week range, 70.21% below the high.
